Compare ANIP & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | AHG |
|---|---|---|
| Founded | 2001 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 1999 | 2017 |
| Metric | ANIP | AHG |
|---|---|---|
| Price | $78.53 | $2.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $110.00 | N/A |
| AVG Volume (30 Days) | ★ 294.9K | 14.1K |
| Earning Date | 05-08-2026 | 08-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 419.23 | N/A |
| EPS | ★ 3.32 | N/A |
| Revenue | ★ $206,547,000.00 | N/A |
| Revenue This Year | $21.01 | N/A |
| Revenue Next Year | $17.59 | N/A |
| P/E Ratio | $23.94 | ★ N/A |
| Revenue Growth | ★ 2.47 | N/A |
| 52 Week Low | $56.71 | $1.08 |
| 52 Week High | $99.50 | $2.50 |
| Indicator | ANIP | AHG |
|---|---|---|
| Relative Strength Index (RSI) | 53.02 | 54.55 |
| Support Level | $78.80 | $2.15 |
| Resistance Level | $83.58 | $2.46 |
| Average True Range (ATR) | 2.41 | 0.18 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 46.30 | 64.05 |
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.